The American Cancer Society and Flatiron Health launched a joint grant-making program that supports both organizations' goals of accelerating cancer research and improving treatment and care options for patients.
The Leukemia & Lymphoma Society announced that it has more than doubled its funding of research focused specifically on childhood blood cancers, adding 20 new research grants valued at more than $13.8 million to its research portfolio in 2019.
The Snowdome Foundation and Leukaemia Foundation joined with the Leukemia & Lymphoma Society to fund four blood cancer research projects with Australian researchers through the LLS Translational Research Program.
I have devoted my career to improving care for people living with cancer. It wasn't until my father was diagnosed with head and neck cancer that I realized just how complex navigating the cancer care experience can be—and how much I had to learn as a caregiver. To improve the lives of people living with cancer, we must focus on more than treatment and address care holistically.
The FY19 Defense Appropriation provides $10 million to the Department of Defense Melanoma Research Program to support innovative, high-impact melanoma research.
The FY19 Defense Appropriation provides $20 million to the Department of Defense Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.
The FY19 Defense Appropriation provides $20 million to the Department of Defense Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.
The FY19 Defense Appropriation provides $10 million to the Department of Defense Melanoma Research Program to support innovative, high-impact melanoma research. FY19 MRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website. The FY19 MRP Focus Areas are listed below: Precursor Lesions, Melanomagenesis, Host Factors, and the... […]
Astellas Pharma Inc. is calling for entries for the fourth annual Astellas Oncology C3 Prize (Changing Cancer Care), a challenge that funds the best non-treatment ideas to improve cancer care for patients, caregivers and their loved ones.
The FY19 Defense Appropriation provides $130 million to the Department of Defense Breast Cancer Research Program to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public. FY19 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted... […]
